YATHARTHYatharth Hospital & Trauma Care Services Ltd.
Yatharth Hospital & Trauma Care Services Q2 FY27 Results: Consolidated Net Profit ₹93.88 Crore on Total Income of ₹833 Crore
- Earnings
- hospitals and healthcare services
Reviewed byKeshav SehgalBlacklitt Research
Yatharth Hospital & Trauma Care Services (NSE: YATHARTH) reported consolidated total income of ₹833.45 crore and net profit of ₹93.88 crore for the quarter ended 30 Sep 2026, and standalone total income of ₹399.19 crore and net profit of ₹65.23 crore, it said in a filing on 03 Nov 2026.
Key highlights
Consolidated
Including its subsidiaries
- Total income: ₹833.45 crore, up 49.9% YoY
- Net profit and EPS: ₹93.88 crore, up 12.7% YoY; basic EPS ₹10.13, up 17.2% YoY
- Profit before tax: ₹126.82 crore, up 11.7% YoY; tax expense ₹32.94 crore
Standalone
The company on its own, without its subsidiaries
- Total income: ₹399.19 crore, up 42.1% YoY
- Net profit and EPS: ₹65.23 crore, up 36.6% YoY; basic EPS ₹6.77, up 36.5% YoY
- Other income: ₹27.98 crore against ₹1.75 crore a year earlier
Summary
| Particulars | Q2 FY27 | Q2 FY26 | YoY | Q1 FY27 | QoQ |
|---|---|---|---|---|---|
| Total income | 833.45 | 555.99 | +49.9% | n/a | n/a |
| 93.88 | 83.29 | +12.7% | n/a | n/a | |
| Profit before tax | 126.82 | 113.51 | +11.7% | n/a | n/a |
| Tax expense | 32.94 | 30.22 | +9.0% | n/a | n/a |
| EPS, basic (₹) | 10.13 | 8.64 | +17.2% | n/a | n/a |
Figures are in ₹ crore; YoY compares with Q2 FY26 and QoQ with Q1 FY27. Click Total income or Net profit to see the rows behind them.
Consolidated total income grew faster than net profit. Income rose 49.9% to ₹833.45 crore, while net profit rose 12.7% to ₹93.88 crore and profit before tax rose 11.7% to ₹126.82 crore. Tax expense of ₹32.94 crore is 26.0% of profit before tax, against ₹30.22 crore on ₹113.51 crore a year earlier.
Consolidated net profit of ₹93.88 crore is ₹28.65 crore higher than standalone net profit of ₹65.23 crore.
The filing's notes on the income tax matter are set out below for the group as a whole.
| Particulars | Q2 FY27 | Q2 FY26 | YoY | Q1 FY27 | QoQ |
|---|---|---|---|---|---|
| 399.19 | 280.84 | +42.1% | n/a | n/a | |
| Revenue from operations | 371.21 | 269.09 | +37.9% | n/a | n/a |
| Other income | 27.98 | 1.75 | n/a | n/a | n/a |
| 65.23 | 47.76 | +36.6% | n/a | n/a | |
| Profit before tax | 82.22 | 64.07 | +28.3% | n/a | n/a |
| Depreciation | 20.65 | 11.01 | +87.7% | n/a | n/a |
| Tax expense | 16.99 | 16.30 | +4.2% | n/a | n/a |
| EPS, basic (₹) | 6.77 | 4.96 | +36.5% | n/a | n/a |
Figures are in ₹ crore; YoY compares with Q2 FY26 and QoQ with Q1 FY27. Click Total income or Net profit to see the rows behind them.
Standalone net profit rose 36.6% to ₹65.23 crore, faster than profit before tax, which rose 28.3% to ₹82.22 crore. Total income rose 42.1% to ₹399.19 crore, and revenue from operations rose 37.9% to ₹371.21 crore.
Other income of ₹27.98 crore is 7.0% of total income this quarter and 34.0% of profit before tax of ₹82.22 crore. Against ₹1.75 crore a year earlier, it is a much larger share of the standalone result. Tax expense of ₹16.99 crore is 20.7% of profit before tax.
Depreciation and amortisation expense is ₹10.56 crore in the quarter, against ₹6.32 crore a year earlier, according to the statement. The standalone EPS of ₹6.77 compares with ₹4.96 a year earlier.
Inference
The filing says the company granted 227,693 employee stock options under ESOP 2024 at an exercise price of ₹10 per option on 10 Aug 2026, vesting up to four years. The company entered into a definitive agreement with Rasmalai Limited, an affiliate of Advent International, under which Advent International will hold 24.9% of the equity on a fully diluted basis; shareholder approval was obtained at the Extraordinary General Meeting on 15 Oct 2026, and the deal is subject to regulatory approvals and customary conditions.
The company says it has filed appeals before the CIT (Appeals) against assessment orders demanding ₹29.66 crore plus interest of ₹11.42 crore, and that it is confident of substantial relief. No provision has been made. The filing does not say when the appeals will be decided or what the outcome will be.
Filed with BSE on . Reference: Original filing (PDF)
Disclaimer:
The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.
